Data-driven analysis of TRP channels in cancer: Linking variation in gene expression to clinical significance

Cancer Genomics and Proteomics

Volumn 13, Issue 1, 2016, Pages 83-90

  Park, Yu Rang ^a   Chun, Jung Nyeo ^b   So, Insuk ^b   Kim, Hwa Jung ^c   Baek, Seunghee ^d   Jeon, Ju Hong ^b,c   Shin, Soo Yong ^a,c  

^a Office of Clinical Research Information   (South Korea)

^b Seoul National University   (South Korea)

^c Asan Medical Center   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

Author keywords

Cancer; Clinical significance; Data driven approach; TRP channel

Indexed keywords

MOLECULAR MARKER; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M2; TRANSIENT RECEPTOR POTENTIAL CHANNEL M3; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; VANILLOID RECEPTOR 4;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER INCIDENCE; CANCER PATIENT; CANCER SURVIVAL; DOWN REGULATION; FEMALE; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; KIDNEY CANCER; LUNG CANCER; MALE; PREDICTIVE VALUE; UPREGULATION; CHEMISTRY; GENETICS; MIDDLE AGED; NEOPLASM; PROGNOSIS;

ADULT; AGED; GENE EXPRESSION; HUMANS; MIDDLE AGED; NEOPLASMS; PROGNOSIS; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84959350249     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Moran MM, McAlexander MA, Biro T and Szallasi A: Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov 10:601-620, 2011.
2. Nilius B and Szallasi A: Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine. Pharmacol Rev 66:676-814, 2014.
3. Nilius B and Owsianik G: The transient receptor potential family of ion channels. Genome Biol 12:218, 2011.
4. Shapovalov G, Lehen'kyi V, Skryma R and Prevarskaya N: TRP channels in cell survival and cell death in normal and transformed cells. Cell Calcium 50:295-302, 2011.
5. Prevarskaya N, Skryma R and Shuba Y: Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 11:609-618, 2011.
6. Shin YC, Shin SY, So I, Kwon D and Jeon JH: TRIP Database: a manually curated database of protein-protein interactions for mammalian TRP channels. Nucleic Acids Res 39:D356-361, 2011.
7. Shin YC, Shin SY, Chun JN, Cho HS, Lim JM, Kim HG, So I, Kwon D and Jeon JH: TRIP database 2.0: a manually curated information hub for accessing TRP channel interaction network. PLoS One 7:e47165, 2012.
8. Chun JN, Lim JM, Kang Y, Kim EH, Shin YC, Kim HG, Jang D, Kwon D, Shin SY, So I and Jeon JH: A network perspective on unraveling the role of TRP channels in biology and disease. Pflugers Arch 466:173-182, 2014.
9. Greene CS and Troyanskaya OG: Chapter 2: Data-driven view of disease biology. PLoS Comput Biol 8:e1002816, 2012.
10. Janes KA and Yaffe MB: Data-driven modelling of signaltransduction networks. Nat Rev Mol Cell Biol 7:820-828, 2006.
11. Sirota M, Dudley JT, Kim J, Chiang AP, Morgan AA, Sweet-Cordero A, Sage J and Butte AJ: Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med 3:96ra77, 2011.
12. Jerby-Arnon L, Pfetzer N, Waldman YY, McGarry L, James D, Shanks E, Seashore-Ludlow B, Weinstock A, Geiger T, Clemons PA, Gottlieb E and Ruppin E: Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality. Cell 158:1199-1209, 2014.
13. Harrell FE Jr., Califf RM, Pryor DB, Lee KL and Rosati RA: Evaluating the yield of medical tests. JAMA 247:2543-2546, 1982.
14. D. B: The area above the ordinal dominance graph and the area below the receiver operating characteristic graph. J Math Psychol 12:387-415, 1975.
15. BH B, M H and RM K: Nonparametric tests of independence for censored data, with applications to heart transplant studies. Reliab Biometr 327-354, 1974.
16. Lehen'kyi V and Prevarskaya N: Oncogenic TRP channels. Adv Exp Med Biol 704:929-945, 2011.
17. Lehen'kyi V, Raphael M, Prevarskaya N: The role of the TRPV6 channel in cancer. J Physiol 590:1369-1376, 2012.
18. Guo H, Carlson JA and Slominski A: Role of TRPM in melanocytes and melanoma. Exp Dermatol 21:650-654, 2012.
19. Yee NS, Brown RD, Lee MS, Zhou W, Jensen C, Gerke H and Yee RK: TRPM8 ion channel is aberrantly expressed and required for preventing replicative senescence in pancreatic adenocarcinoma: potential role of TRPM8 as a biomarker and target. Cancer Biol Ther 13:592-599, 2012.
20. Gautier M, Dhennin-Duthille I, Ay AS, Rybarczyk P, Korichneva I and Ouadid-Ahidouch H: New insights into pharmacological tools to TR (i) P cancer up. Br J Pharmacol 171:2582-2592, 2014.
21. Deng D, Liu Z and Du Y: Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers. Adv Genet 71:125-176, 2010.
22. Jones PA: Epigenetics in carcinogenesis and cancer prevention. Ann NY Acad Sci 983:213-219, 2003.
23. Liberati S, Morelli MB, Nabissi M, Santoni M and Santoni G: Oncogenic and anti-oncogenic effects of transient receptor potential channels. Curr Top Med Chem 13:344-366, 2013.
24. Nielsen N, Lindemann O, Schwab A: TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration. Br J Pharmacol 171:5524-5540, 2014.